首页> 美国卫生研究院文献>Polymers >Recent Advances on Octahedral Polypyridyl Ruthenium(II) Complexes as Antimicrobial Agents
【2h】

Recent Advances on Octahedral Polypyridyl Ruthenium(II) Complexes as Antimicrobial Agents

机译:八面体聚吡啶钌(II)配合物作为抗菌剂的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent developments of therapeutic agents based on transition metals have attracted a great deal of attention. Metal drugs have advantages over other small molecule drugs, and it was demonstrated that, in a number of studies, they played an important role in pharmaceutical chemical research and clinical chemotherapy of cancers. It is worthwhile mentioning that octahedral polypyridyl ruthenium(II) complexes have shown remarkable applications in chemical biology and medicinal chemistry over the last decade. However, only very recently has there been comprehensive interest in their antimicrobial properties due to metal-related toxic concerns or neglected potential roles in microbiological systems. Our review will highlight the recent developments in octahedral polypyridyl ruthenium(III) complexes that have exhibited significant antimicrobial activities and will discuss the relationship between the chemical structure and biological process of ruthenium complexes, in both bacterial and fungal cells.
机译:基于过渡金属的治疗剂的最新发展引起了极大的关注。金属药物具有优于其他小分子药物的优势,并且在许多研究中证明,金属药物在药物化学研究和癌症的临床化学治疗中起着重要作用。值得一提的是,在过去的十年中,八面体聚吡啶基钌(II)配合物在化学生物学和药物化学中已显示出非凡的应用。但是,由于金属相关的毒性问题或在微生物系统中被忽视的潜在作用,直到最近才对其抗菌特性产生了广泛的兴趣。我们的综述将着重介绍八面体聚吡啶钌(III)配合物的最新发展,这些配合物表现出显着的抗菌活性,并将讨论细菌和真菌细胞中钌配合物的化学结构与生物学过程之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号